Puma Biotechnology reported $34.89M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.78M 332K
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amgen AMGN:US $ 4677M 451M
Biogen BIIB:US $ 1777.9M 295.8M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Daiichi Sankyo 4568:JP Y 145095M 43967M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Exelixis EXEL:US $ 342.78M 95.45M
Gilead Sciences GILD:US $ 5166M 549M
Glaxosmithkline GSK:US $ 6135M 283M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
MacroGenics MGNX:US 11.05M 2.15M
Moderna Inc MRNA:US 5.05B 1.21B
Novartis NOVN:VX 9.06B 463M
Pfizer PFE:US $ 15651M 1627M
Ptc Therapeutics PTCT:US $ 138.6M 17.3M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Takeda 4502:JP Y 564909M 54981M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
Vanda Pharmaceuticals VNDA:US $ 54.53M 7.26M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M